Last quarter (Q3 2023), Tango Therapeutics's total revenue was $10.73M, an increase of 55.09% from the same quarter last year. In Q3, Tango Therapeutics's net income was $-21.43M. See Tango Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21
Total Revenue	$ 32.51M	$ 24.86M	$ 37.04M
Cost of Revenue	-	-	-
Gross Profit	$ 37.51M	$ 24.86M	$ 37.04M
Operating Expense	$ 73.28M	$ 135.93M	$ -95.23M
Operating Income	$ -109.73M	$ -111.07M	$ -58.19M
Net Non Operating Interest Income Expense	$ 3.32M	$ 1.46M	-
Other Income Expense	$ -9.02M	$ 1.45M	$ 1.03M
Pretax Income	$ -98.40M	$ -108.12M	$ -57.94M
Tax Provision	$ 138.00K	$ 54.00K	$ 292.00K
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	$ -96.55M	$ -111.12M	$ -59.02M
Basic EPS	$ -1.40	$ -1.23	$ -0.94
Diluted EPS	$ -1.11	$ -1.23	$ -0.94
Basic Average Shares	$ 361.40M	$ 87.82M	$ 62.11M
Diluted Average Shares	$ 361.40M	$ 87.82M	$ 62.11M
Dividend Per Share	-	-	-
Total Operating Income As Reported	-	-	-
Reported Normalized Basic E P S	-	-	-
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Total Expenses	$ 73.28M	$ 135.93M	$ -95.23M
Net Income From Continuing And Discontinued Operation	$ -98.89M	$ -108.18M	$ -59.02M
Normalized Income	$ -33.88M	-	-
Interest Expense	-	-	-
EBIT	$ -103.37M	$ -109.58M	$ -58.44M
EBITDA	$ -98.43M	$ -105.56M	$ -56.47M

Currency in USD

Tango Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing